Digital health can assist people with diabetes with better disease management. Scant research exists on whether remote patient monitoring (RPM) supported by digital therapeutics impact long-term type 2 diabetes (T2D) outcomes and costs.
Glooko conducted this health economics outcomes research (HEOR) study using a mathematical simulation model to estimate the impact of remote patient monitoring and digital therapeutics technology on diabetes outcomes, healthcare resource use and costs.
In a randomized controlled trial of remote patient monitoring and digital therapeutics, the intervention resulted in significantly improved HbA1c. Incorporating these results into a microsimulation model of longer-term complications, mortality and costs demonstrated the potential for remote patient monitoring and digital therapeutics to elicit health gains and cost savings among people with diabetes.
Download to view the full findings of Glooko’s first HEOR study.
DOWNLOAD